Latest Breaking News On - Urogen pharma ltd - Page 7 : comparemela.com

UroGen Pharma Ltd (NASDAQ:URGN) Shares Sold by Meitav Investment House Ltd

Meitav Investment House Ltd. reduced its stake in UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 13.3% in the third quarter, HoldingsChannel reports. The fund owned 91,456 shares of the company’s stock after selling 14,056 shares during the quarter. Meitav Investment House Ltd.’s holdings in UroGen Pharma were worth $1,295,000 at the end of the […]

Urogen pharmaLazard asset managementMeitav investment house ltdUrogen pharma ltdAllspring global investments holdingsAcadian asset managementMeitav investment houseFree reportInvestment houseAsset managementGlobal investments holdingsGen pharmaGet free reportGen pharma ltdVisit holdingschannelUrogen pharma daily

UGN-102 Yields CRs in 4 out of 5 Patients With Intermediate-Risk NMIBC

UGN-102 produced a high complete response rate in patients with low-grade, intermediate-risk NMIBC in the phase 3 ENVISION trial. UGN-102 produced a high complete response rate in patients with low-grade, intermediate-risk NMIBC in the phase 3 ENVISION trial.

New jerseyUnited statesSandip prasadMorristown medical centerUrogen pharma ltdSociety of urologic oncology annual meetingUrologic oncology annual meetingUrogen pharma

Reviewing Petros Pharmaceuticals (NASDAQ:PTPI) & UroGen Pharma (NASDAQ:URGN)

UroGen Pharma (NASDAQ:URGN – Get Free Report) and Petros Pharmaceuticals (NASDAQ:PTPI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Valuation & Earnings This table compares UroGen […]

New yorkUnited statesNew jerseyUrogen pharmaUrogen pharma ltdPetros pharmaceuticals incPetros pharmaceuticalsAgenus incGet free reportPetros pharmaceuticalGen pharmaGiven petros pharmaceuticalGen pharma ltdPrescription medicationsUrogen pharma dailyNasdaq urgn

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesCindy romanoVincent perroneUrogen pharma ltdGen pharmaUrogen pharma

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units ("RSUs") to 17 new employees in.

New jerseyUnited statesUrogen pharma ltdGen pharmaUrogen pharma